The purpose of the company is the development, production, quality control and assurance, licensing, marketing, distribution, and monitoring of pharmaceutical products both domestically and internationally. The company may engage in all activities related to quality assurance and quality control, regulatory affairs, production, distribution, logistics, pharmacovigilance, medical care, sales and marketing, as well as international coordination and administration. This includes, in particular, compliance with regulatory standards such as GMP and GDP, management of licenses and permits, cooperation with supervisory authorities, control of supply chains, monitoring of drug safety, scientific and medical support, development and implementation of distribution and marketing strategies, as well as coordination and support of affiliated companies and subsidiaries, including the management of intellectual property, strategic planning, administrative services, compliance, and operational alignment. The company may establish branches and subsidiaries both domestically and internationally, participate in other companies, assume representations, and conduct any business activities and conclude contracts of any kind that may promote the company's purpose or are directly or indirectly related to the company's purpose. The company may acquire, hold, manage, encumber, and sell real estate both domestically and internationally, except for transactions prohibited by the Federal Law on the Acquisition of Real Estate by Persons Abroad (BewG). The company is part of a group and may consider the interests of the group in pursuing its corporate purpose. In particular, the company may grant loans and other direct or indirect financings to its direct and indirect subsidiaries and third parties, including within the framework of cash pooling agreements (incl. Zero Balancing), and provide securities of any kind for the liabilities of these parties, including by way of pledges on or fiduciary transfers of shares of the company or guarantees of any kind. This may also be done without consideration, on preferential terms, without interest, excluding the profit-seeking nature of the company and/or assuming clustering risks.
Outbound Leads by COHAGA